ClinicalTrials.gov record
Recruiting No phase listed Observational

Study of the Disease Process of Lymphangioleiomyomatosis

ClinicalTrials.gov ID: NCT00001465

Public ClinicalTrials.gov record NCT00001465. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 7:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)

Study identification

NCT ID
NCT00001465
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Enrollment
2,000 participants

Conditions and interventions

Interventions

  • Toshibia Aquilion One CT Device

Device

Eligibility (public fields only)

Age range
16 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 17, 1995
Primary completion
Not listed
Completion
Not listed
Last update posted
May 6, 2026

Started 1995

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
National Institutes of Health Clinical Center Bethesda Maryland 20892 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001465, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001465 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →